# Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis

> **NCT05043194** · NA · UNKNOWN · sponsor: **Wei Liu** · enrollment: 80 (estimated)

## Conditions studied

- Cholestasis of Parenteral Nutrition

## Interventions

- **DRUG:** Ursodeoxycholic Acid 250 Mg Oral Capsule

## Key facts

- **NCT ID:** NCT05043194
- **Lead sponsor:** Wei Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043194, "Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05043194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*